Infectious agents and Alzheimer's disease
Open accessThe DOI matches its Crossref record; 231 of the 231 references it cites were found in a registry or an index.
Abstract
Alzheimer’s disease (AD) is the leading cause of dementia worldwide. Individuals affected by the disease gradually lose their capacity for abstract thinking, understanding, communication and memory. As populations age, declining cognitive abilities will represent an increasing global health concern. While AD was first described over a century ago, its pathogenesis remains to be fully elucidated. It is believed that cognitive decline in AD is caused by a progressive loss of neurons and synapses that lead to reduced neural plasticity. AD is a multifactorial disease affected by genetic and environmental factors. The molecular hallmarks of AD include formation of extracellular β amyloid (Aβ) aggregates, neurofibrillary tangles of hyperphosphorylated tau protein, excessive oxidative damage, an imbalance of biothiols, dysregulated methylation, and a disproportionate inflammatory response. Recent reports have shown that viruses (e.g., Herpes simplex type 1, 2, 6A/B; human cytomegalovirus, Epstein-Barr virus, hepatitis C virus, influenza virus, and severe acute respiratory syndrome coronavirus 2, SARS-CoV-2), bacteria (e.g., Treponema pallidum, Borrelia burgdorferi, Chlamydia pneumoniae, Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythia, Fusobacterium nucleatum, Aggregatibacter actinomycetemcmitans, Eikenella corrodens, Treponema denticola, and Helicobacter pylori), as well as eukaryotic unicellular parasites (e.g., Toxoplasma gondii) may factor into cognitive decline within the context of AD. Microorganisms may trigger pathological changes in the brain that resemble and/or induce accumulation of Aβ peptides and promote tau hyperphosphorylation. Further, the mere presence of infectious agents is suspected to induce both local and systemic inflammatory responses promoting cellular damage and neuronal loss. Here we review the influence of infectious agents on the development of AD to inspire new research in dementia based on these pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several studies have shown that viral infections, such as Herpes simplex encephalitis, Epstein-Barr virus, Eastern Equine Encephalitis virus (EEEV), Western Equine Encephalitis virus (WEEV), and Venezuelan Equine Encephalitis Virus (VEEV), correlate with negative neurological consequences even after the acute phase”
From Arbovirus infection increases the risk for the development of neurodegenerative disease pathology in the murine model (2024) · cites this paper as Piekut et al., 2022
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“suggesting a potential role in developing and progressing neurodegenerative disorders, particularly AD (Bantle et al., 2019; Piekut et al., 2022; Ronca et al., 2017).”
From Arbovirus infection increases the risk for the development of neurodegenerative disease pathology in the murine model (2024) · cites this paper as Piekut et al., 2022
In the citing paper
“Furthermore, SARS-CoV-2 directly induces AD pathogenesis such as neuronal damage and amyloid processing,278–280 as well as PD pathogenesis including α-syn aggregation and dopaminergic neuronal loss in various models.281”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [280]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–231 of 231
Al-Atrache, Z., Lopez, D. B., Hingley, S. T., & Appelt, D. M. (2019) · BMC Neuroscience · doi:10.1186/s12868-019-0489-5 · Cited by 37
Lee, K. H., Kwon, D. E., Do Han, K., La, Y., & Han, S. H. (2020) · BMC Neurology · doi:10.1186/s12883-020-01776-3 · Cited by 35
McFarland, R., Wang, Z. T., Jouroukhin, Y., Li, Y., Mychko, O., Coppens, I., Xiao, J., Jones‐Brando, L. V., Yolken, R. H., Sibley, L. D., et al. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.03.023 · Cited by 34
Cohrs, R. J., Mahalingam, R., Dueland, A. N., Wolf, W. J., Wellish, M., & Gilden, D. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.supplement_1.s24 · Cited by 33
Propionibacterium acnes in the cortex of patients with Alzheimer's disease
Kornhuber, H. H. (1996) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02274902 · Cited by 32
Li, Q., Ali, M. A., Wang, K., Sayre, D., Hamel, F. G., Fischer, E. R., Bennett, R. G., & Cohen, J. I. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011327 · Cited by 32
Zerboni, L., Che, X., Reichelt, M., Qiao, Y., Gu, H., & Arvin, A. M. (2012) · Journal of Virology · doi:10.1128/jvi.01375-12 · Cited by 31
Stebbins, R. C., Noppert, G. A., Yang, Y. C., Dowd, J. B., Simanek, A. M., & Aiello, A. E. (2020) · American Journal of Epidemiology · doi:10.1093/aje/kwaa238 · Cited by 31
Holle, R., Gräßel, E., Ruckdäschel, S., Wunder, S., Mehlig, H., Marx, P., Pirk, O., Butzlaff, M., Kunz, S., & Lauterberg, J. (2009) · BMC Health Services Research · doi:10.1186/1472-6963-9-91 · Cited by 30
Primary target cells of herpes simplex virus type 1 in the hippocampus
Ando, Y., Kitayama, H., Kawaguchi, Y., & Koyanagi, Y. (2008) · Microbes and Infection · doi:10.1016/j.micinf.2008.09.005 · Cited by 28
Analysis by immunoblotting ofToxoplasma gondii exo-antigens and comparison with somatic antigens
Bessières, M.-H., Breton, S. L., & Séguéla, J. P. (1992) · Parasitology Research · doi:10.1007/bf00931730 · Cited by 26
White, M. R., Kandel, R., Hsieh, I.-N., Luna, X. D., & Hartshorn, K. L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194001 · Cited by 24
Varga, M., Görög, D., Kári, D., Környei, E., Kis, É., Túryné, H. J., Jankovics, I., Péter, Á., Toronyi, É., Sárváry, E., et al. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.03.067 · Cited by 23
Cognitive impairments in HCV infection: From pathogenesis to neuroimaging
Amirsardari, Z., Rahmani, F., & Rezaei, N. (2019) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2019.1652728 · Cited by 22
Impact of sequence on the molecular assembly of short amyloid peptides
Wagoner, V. A., Cheon, M., Chang, I., & Hall, C. K. (2014) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24515 · Cited by 21
Jayasuriya, A. N., Itzhaki, R. F., Wozniak, M. A., Patel, R., Smit, E., Noone, R., Gilleran, G., Taylor, S. R., & White, D. (2008) · Sexually Transmitted Infections · doi:10.1136/sti.2008.032367 · Cited by 20
The Intersection between COVID-19, the Gene Family of ACE2 and Alzheimer’s Disease
Haghighi, M. M., Kakhki, E. G., Sato, C., Ghani, M., & Rogaeva, E. A. (2020) · Neuroscience Insights · doi:10.1177/2633105520975743 · Cited by 20
Bernstein, H., Keilhoff, G., Dobrowolny, H., & Steiner, J. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-00995-1 · Cited by 19
The another side of COVID‐19 in Alzheimer’s disease patients: Drug‐drug interactions
Balli, N., Kara, E., & Demirkan, K. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13596 · Cited by 18
Herpes simplex encephalitis presenting with exclusively frontal lobe involvement
Taylor, S. W., Lee, D. H., & Jackson, A. C. (2007) · Journal of NeuroVirology · doi:10.1080/13550280701491131 · Cited by 16
CanToxoplasma gondiiPave the Road for Dementia?
Saftawy, E. A. E., Amin, N. M. A., Sabry, R. M., El‐Anwar, N., Shash, R. Y., Elsebaie, E. H., & Wassef, R. M. (2020) · Journal of Parasitology Research · doi:10.1155/2020/8859857 · Cited by 15
Terasaki, S., Kameyama, T., & Yamamoto, S. (1997) · The Kurume Medical Journal · doi:10.2739/kurumemedj.44.61 · Cited by 13
Alvarado‐Esquivel, C., Rico-Almochantaf, Y. D. R., Hernández‐Tinoco, J., Quiñones-Canales, G., Sánchez-Anguiano, L. F., Torres-González, J., Schott, B. H., Liesenfeld, O., & Dunay, I. R. (2017) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2017.00033 · Cited by 13
Genetic Editing and Pharmacogenetics in Current And Future Therapy Of Neurocognitive Disorders
Prendecki, M., Kowalska, M., Totoń, E., & Kozubski, W. P. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200422152440 · Cited by 11
Self-citationDaugherty, A. M., Chopra, T., Korzeniewski, S. J., & Levy, P. D. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113557 · Cited by 10
Kushawaha, A., Mobarakai, N. K., & Tolia, J. (2009) · Cases Journal · doi:10.4076/1757-1626-2-6299 · Cited by 7
S100B and Latent Toxoplasmosis in Alzheimer’s disease
Ayyıldız, H. (2019) · International journal of medical biochemistry/International journal of medical biochemistry : · doi:10.14744/ijmb.2019.47965 · Cited by 7
Wong, M. C. S., Wong, S. H., Huang, J., & Yan, B. P. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12952 · Cited by 7
Kam, A. C., Dan, N. G., Maclean, J., & Higgins, D. (1999) · Journal of Clinical Neuroscience · doi:10.1016/s0967-5868(99)90519-2 · Cited by 6
Ukraintseva, S. V., Akushevich, I. V., Yashkin, A. P., Kravchenko, J. S., Arbeev, K. G., Kulminski, A. M., Politi, R., Tropsha, A., & Yashin, A. I. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.06.2217 · Cited by 5
ApoE4-carrying Human Astrocytes Oversupply Cholesterol into Neurons and Promote Aβ GenerationPreprint
Lee, S.-I., Jeong, W., Cho, S., Lee, H. G., Jang, Y., Lin, Y.-T., Tsai, L., & Seo, J. (2020) · Research Square · doi:10.21203/rs.3.rs-122857/v1 · Cited by 3
Research works printed but not linked: 3
- Prince M, Wimo A, Guerchet M, Ali GC, Wu YT, Prina M. World alzheimer report 2015. The global impact of dementia: an analysis of prevalence, incidence, cost and trends updates. Alzheimer’s Disease International. 2015; 2015: 1–87.
- Boutoleau-Bretonnière C, Pouclet-Courtemanche H, Gillet A, Bernard A, Deruet AL, Gouraud I, et al. The effects of confinement on neuropsychiatric symptoms in alzheimer’s disease during the COVID-19 crisis. Journal of Alzheimer’s Disease. 2020; 76: 41–47. · DOI · Paper page
- Alzheimer A. Uber eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und psychisch-gerichtliche Medizin. 1907; 18: 177–179. (In German)
Cited by
Virus exposure and neurodegenerative disease risk across national biobanks
Levine, K. S., Leonard, H. L., Blauwendraat, C., Iwaki, H., Johnson, N., Bandres-Ciga, S., Ferrucci, L., Faghri, F., Singleton, A. B., & Nalls, M. A. (2023) · Neuron · doi:10.1016/j.neuron.2022.12.029 · Cited by 341
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
“Furthermore, SARS-CoV-2 directly induces AD pathogenesis such as neuronal damage and amyloid processing, 278 – 280 as well as PD pathogenesis including α -syn aggregation and dopaminergic neuronal loss in various models.”
Rao, R. V., Subramaniam, K. G., Gregory, J., Bredesen, A. L., Coward, C., Okada, S., Kelly, L., & Bredesen, D. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021659 · Cited by 102
Alzheimer’s disease as a viral disease: Revisiting the infectious hypothesis
Bruno, F., Abondio, P., Bruno, R., Ceraudo, L., Paparazzo, E., Citrigno, L., Luiselli, D., Bruni, A. C., Passarino, G., Colao, R., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102068 · Cited by 88
Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases
Korczowska-Łącka, I., Słowikowski, B. K., Piekut, T., Hurła, M., Banaszek, N., Szymanowicz, O., Jagodziński, P. P., Kozubski, W. P., Permoda-Pachuta, A., & Dorszewska, J. (2023) · Antioxidants · doi:10.3390/antiox12101811 · Cited by 98
Self-citation
Metadata
- Authors
- Piekut, T., Hurła, M., Banaszek, N., Szejn, P., Dorszewska, J., Kozubski, W., & Prendecki, M.
- Affiliations
- Poznan University of Medical Sciences (PL)
- Corresponding author
- Dorszewska, Jolanta
- Venue
- Journal of Integrative Neuroscience
- Publisher
- IMR Press
- Published
- 2022-03-28
- Volume
- 21
- Issue
- 2
- Pages
- 73-73
- ISSN
- 0219-6352 (ISSN-L)
- 1757-448X
- OpenAlex
- W4220974380
- Cited by
- 123
- References
- 230
- Citations by year
- 2026: 16 · 2025: 26 · 2024: 42 · 2023: 33 · 2022: 6
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Integrative Neuroscience (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- European Commission
- Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu
- Narodowe Centrum Badań i Rozwoju
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, infectious agents, dementia, amyloid-beta, tau hyperphosphorylation, neuroinflammation, viral pathogens, pathogenic bacteria, Treponema pallidum, Helicobacter pylori, Toxoplasma gondii, SARS-CoV-2, herpes simplex virus, human cytomegalovirus, Epstein-Barr virus, hepatitis C virus, Porphyromonas gingivalis, Fusobacterium nucleatum, oxidative stress, methylation, cognitive decline
- MeSH terms
- COVID-19, SARS-CoV-2, Alzheimer Disease, Herpesvirus 4, Human, Humans, Epstein-Barr Virus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.